GFG Capital’s Colgate-Palmolive CL Stock Holding History

GFG Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-77	Closed	-$7K	–	109
2025 Q2	$7K	Buy	+77	New	+$7.03K	﹤0.01%	237

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GFG Capital's CL Position: Q3 2025 in Review

GFG Capital sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 77 shares — an estimated $7K sold.

GFG Capital first reported a position in CL in Q2 2025 and held it in 1 quarter. The position peaked at $7K in Q2 2025. 1,847 funds tracked by Wall St. Rank hold CL as of Q3 2025.

GFG Capital reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
GFG Capital sold 77 Colgate-Palmolive shares in Q3 2025, an estimated $7K.
GFG Capital first reported a position in Colgate-Palmolive in Q2 2025 and held it in 1 quarter.
GFG Capital's Colgate-Palmolive position peaked at $7K in Q2 2025.
1,847 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on GFG Capital's 13F filing for Q3 2025, filed 7 Oct 2025.